These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 847450

  • 1. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J.
    Schweiz Med Wochenschr; 1977 Apr 09; 107(14):474-9. PubMed ID: 847450
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R.
    Neurol Neurocir Psiquiatr; 1976 Apr 09; 17(4):293-300. PubMed ID: 1018729
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L, De la Garza R.
    Arch Invest Med (Mex); 1977 Apr 09; 8(2):123-8. PubMed ID: 907417
    [Abstract] [Full Text] [Related]

  • 4. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Podiwinsky F, Mentasti M, Riederer P, Birkmayer W.
    Wien Klin Wochenschr; 1979 May 11; 91(10):332-7. PubMed ID: 452602
    [Abstract] [Full Text] [Related]

  • 5. L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease.
    Celesia GG, Wanamaker WM.
    Dis Nerv Syst; 1976 Mar 11; 37(3):123-5. PubMed ID: 1253661
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
    Hanzal F.
    MMW Munch Med Wochenschr; 1976 May 14; 118(20):653-6. PubMed ID: 818540
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T, Yahr MD.
    Ann Neurol; 1995 Jan 14; 37(1):95-8. PubMed ID: 7818264
    [Abstract] [Full Text] [Related]

  • 9. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G, Casacchia M, Zamponi A, Agnoli A.
    Acta Neurol (Napoli); 1976 Jan 14; 31(4):479-48. PubMed ID: 1037427
    [No Abstract] [Full Text] [Related]

  • 10. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
    Admani AK, Verma S, Cordingley GJ, Harris RI.
    Pharmatherapeutica; 1985 Jan 14; 4(2):132-40. PubMed ID: 4059292
    [Abstract] [Full Text] [Related]

  • 11. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
    Martínez-Lage JM, Burguera JA, Deldago G, Zubieta JL.
    Arch Neurobiol (Madr); 1978 Jan 14; 41(1):3-18. PubMed ID: 697513
    [No Abstract] [Full Text] [Related]

  • 12. [Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    Rondot P.
    Rev Prat; 1974 Mar 11; 24(15):1211-2, 1215-6, 1219. PubMed ID: 4416964
    [No Abstract] [Full Text] [Related]

  • 13. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA, Pfeiffer RF, Tagliati M, Kastenholz KV, DeRoche C, Slevin JT.
    Clin Ther; 2005 Jan 11; 27(1):58-63. PubMed ID: 15763606
    [Abstract] [Full Text] [Related]

  • 14. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
    Savery F.
    Dis Nerv Syst; 1977 Aug 11; 38(8):605-8. PubMed ID: 328244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records].
    Szulc-Kuberska J, Niewodniczy A, Poźniak-Patewics E, Wolczyk-Orzechowska M.
    Neurol Neurochir Pol; 1975 Aug 11; 9(5):611-5. PubMed ID: 1186952
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Lieberman A, Goodgold A, Jonas S, Leibowitz M.
    Neurology; 1975 Oct 11; 25(10):911-6. PubMed ID: 1101099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.